Filing Details
- Accession Number:
- 0001179110-12-016631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-30 13:53:05
- Reporting Period:
- 2012-11-28
- Filing Date:
- 2012-11-30
- Accepted Time:
- 2012-11-30 13:53:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1020055 | M James Denny | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-11-28 | 36,700 | $19.44 | 273,858 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-11-28 | 27,300 | $28.68 | 301,158 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-28 | 20,000 | $73.91 | 281,158 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-28 | 36,700 | $0.00 | 36,700 | $19.44 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-28 | 27,300 | $0.00 | 27,300 | $28.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-05-10 | No | 4 | M | Direct | |
40,200 | 2016-05-10 | No | 4 | M | Direct |
Footnotes
- Sale prices reported for the transactions reported here range from $73.75 to $74.12. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Options vested 100% at time of grant.